Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 7,411 | 4,112 | 30,482 | 42,220 | 35,368 |
| Gross Profit | 7,411 | 4,112 | 30,482 | 42,220 | 35,368 |
| Operating Expenses | 131,493 | 115,221 | 124,573 | 125,863 | 111,604 |
| Operating Income | -124,082 | -111,109 | -94,091 | -83,643 | -76,236 |
| Interest Expense | 8,703 | 7,949 | 0 | 26 | 0 |
| Other Income | -30,106 | -1,752 | -707 | -4,537 | 2,496 |
| Pre-tax Income | -162,890 | -120,809 | -94,798 | -88,206 | -73,740 |
| Income Tax | 4,585 | -257 | 2,170 | N/A | N/A |
| Net Income Continuous | -167,475 | -120,552 | -96,968 | -88,206 | -73,740 |
| Minority Interests | -1,064 | -1,193 | N/A | N/A | N/A |
| Net Income | $-166,411 | $-119,359 | $-96,968 | $-88,206 | $-73,740 |
| EPS Basic Total Ops | -12.85 | -14.53 | -12.61 | -12.97 | -12.12 |
| EPS Basic Continuous Ops | -12.96 | -14.66 | -12.58 | -12.95 | -12.09 |
| EPS Diluted Total Ops | -12.85 | -14.53 | -12.61 | -13.09 | -12.12 |
| EPS Diluted Continuous Ops | -12.96 | -14.66 | -12.58 | -12.93 | -12.09 |
| EPS Diluted Before Non-Recurring Items | -9.84 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-119,454 | $-105,590 | $-89,022 | $-79,854 | $-72,884 |